Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein‐coupled receptor structure and function
- 3 August 2017
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (21) , 4009-4025
Abstract
Drug development targeting GPCRs often utilizes model heterologous cell expression systems, reflecting an implicit assumption that the membrane environment has little functional impact on these receptors or on their responsiveness to drugs. However, much recent data have illustrated that membrane components can have an important functional impact on intrinsic membrane proteins. This review is directed toward gaining a better understanding of the structure of the plasma membrane in health and disease, and how this organelle can influence GPCR structure, function and regulation. It is important to recognize that the membrane provides a potential mode of lateral allosteric regulation of GPCRs and can affect the effectiveness of drugs and their biological responses in various disease states, which can even vary among individuals across the population. The type 1 cholecystokinin receptor is reviewed as an exemplar of a class A GPCR that is affected in this way by changes in the plasma membrane.Linked Articles: This article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visithttp://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21/issuetocKeywords
This publication has 194 references indexed in Scilit:
- Modulation of the Interaction between Neurotensin Receptor NTS1 and Gq Protein by LipidJournal of Molecular Biology, 2012
- Crystal structure of the β2 adrenergic receptor–Gs protein complexNature, 2011
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human DiseasesCancer Cell, 2010
- Phospholipids Are Needed for the Proper Formation, Stability, and Function of the Photoactivated Rhodopsin−Transducin ComplexBiochemistry, 2009
- Switch-like Control of SREBP-2 Transport Triggered by Small Changes in ER Cholesterol: A Delicate BalanceCell Metabolism, 2008
- Deletion of Cavin/PTRF Causes Global Loss of Caveolae, Dyslipidemia, and Glucose IntoleranceCell Metabolism, 2008
- A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic ReceptorStructure, 2008
- Protein Sensors for Membrane SterolsCell, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Caveolin, a protein component of caveolae membrane coatsCell, 1992